Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NovaBay Pharmaceuticals Company Profile (NYSE:NBY)

Consensus Ratings for NovaBay Pharmaceuticals (NYSE:NBY) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.00 (171.96% upside)

Analysts' Ratings History for NovaBay Pharmaceuticals (NYSE:NBY)
Show:
DateFirmActionRatingPrice TargetActions
4/29/2015Maxim GroupInitiated CoverageBuy$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2014Edison Investment ResearchPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)